Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dunning

Showing results (191-200 of 536) with videos related to

Pageof 54
Sort By:
Nature Genetics|November 4, 2000
A common variant in BRCA2 is associated with both breast cancer risk and prenatal viabilityC S Healey, A M Dunning, M D Teare, et al.
International Journal of Radiation Oncology, Biology, Physics|May 25, 2011
Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studiesGillian C Barnett, Catharine M L West, Charlotte E Coles, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Genetic variation in the chromosome 17q23 amplicon and breast cancer riskLinda E Kelemen, Xianshu Wang, Zachary S Fredericksen, et al.
Plos One|August 10, 2012
Genetic variants in ER cofactor genes and endometrial cancer riskYuqing Li, Hui-Qi Low, Jia Nee Foo, et al.
British Journal of Cancer|January 18, 2022
A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositisLine M H Schack, Elnaz Naderi, Laura Fachal, et al.
Journal of Medical Genetics|August 6, 2017
Rare, protein-truncating variants in <i>ATM</i>, <i>CHEK2</i> and <i>PALB2</i>, but not <i>XRCC2</i>, are associated with increased breast cancer risksBrennan Decker, Jamie Allen, Craig Luccarini, et al.
Transplantation Proceedings|March 27, 2001
Temporary treatment with sirolimus and low-trough cyclosporine prevents acute islet allograft rejection, and combination with starch-conjugated deferoxamine promotes islet engraftment in the preclinical pig modelS Shibata, S Matsumoto, J Sageshima, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer riskBettina Kuschel, Georgia Chenevix-Trench, Amanda B Spurdle, et al.
The Journal of Nutrition|October 28, 2005
Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma androgen concentrations in menYen-Ling Low, James I Taylor, Philip B Grace, et al.
Cancer Research|May 17, 2003
A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancerAlison M Dunning, Peter D Ellis, Simon McBride, et al.
Pageof 54

Showing results (191-200 of 536) with videos related to

Sort By:
Pageof 54
Nature Genetics|November 4, 2000
A common variant in BRCA2 is associated with both breast cancer risk and prenatal viabilityC S Healey, A M Dunning, M D Teare, et al.
International Journal of Radiation Oncology, Biology, Physics|May 25, 2011
Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studiesGillian C Barnett, Catharine M L West, Charlotte E Coles, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Genetic variation in the chromosome 17q23 amplicon and breast cancer riskLinda E Kelemen, Xianshu Wang, Zachary S Fredericksen, et al.
Plos One|August 10, 2012
Genetic variants in ER cofactor genes and endometrial cancer riskYuqing Li, Hui-Qi Low, Jia Nee Foo, et al.
British Journal of Cancer|January 18, 2022
A genome-wide association study of radiotherapy induced toxicity in head and neck cancer patients identifies a susceptibility locus associated with mucositisLine M H Schack, Elnaz Naderi, Laura Fachal, et al.
Journal of Medical Genetics|August 6, 2017
Rare, protein-truncating variants in <i>ATM</i>, <i>CHEK2</i> and <i>PALB2</i>, but not <i>XRCC2</i>, are associated with increased breast cancer risksBrennan Decker, Jamie Allen, Craig Luccarini, et al.
Transplantation Proceedings|March 27, 2001
Temporary treatment with sirolimus and low-trough cyclosporine prevents acute islet allograft rejection, and combination with starch-conjugated deferoxamine promotes islet engraftment in the preclinical pig modelS Shibata, S Matsumoto, J Sageshima, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer riskBettina Kuschel, Georgia Chenevix-Trench, Amanda B Spurdle, et al.
The Journal of Nutrition|October 28, 2005
Polymorphisms in the CYP19 gene may affect the positive correlations between serum and urine phytoestrogen metabolites and plasma androgen concentrations in menYen-Ling Low, James I Taylor, Philip B Grace, et al.
Cancer Research|May 17, 2003
A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancerAlison M Dunning, Peter D Ellis, Simon McBride, et al.
Pageof 54